Prelude Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-239,791
| Closed | -$23.3M | – | 2418 |
|
|
2019
Q3 | $23.3M | Buy |
239,791
+5,541
| +2% | +$555K | 1.05% | 8 |
|
|
2019
Q2 | $24M | Buy |
234,250
+128,681
| +122% | +$13.9M | 1.18% | 13 |
|
|
2019
Q1 | $12M | Buy |
+105,569
| New | +$7.76M | 0.68% | 19 |
|
|
2018
Q4 | – | Sell |
-103
| Closed | -$6K | – | 2355 |
|
|
2018
Q3 | $6K | Buy |
+103
| New | +$7.04K | ﹤0.01% | 1625 |
|
|
2017
Q4 | – | Sell |
-2,220
| Closed | -$198K | – | 1879 |
|
|
2017
Q3 | $198K | Sell |
2,220
-3,167
| -59% | -$240K | 0.02% | 657 |
|
|
2017
Q2 | $322K | Buy |
+5,387
| New | +$301K | 0.03% | 439 |
|
|
2015
Q4 | – | Sell |
-3,678
| Closed | -$153K | – | 1796 |
|
|
2015
Q3 | $153K | Hold |
3,678
| – | – | 0.02% | 702 |
|
|
2015
Q2 | $222K | Buy |
+3,678
| New | +$243K | 0.03% | 550 |
|